Personalized skin
CUTISS AG
Incorporated
08.03.2017Headquarters
SchlierenSupport
CUTISS grows human skin in the lab for patients that suffer from skin defects (e.g. burns). CUTISS bio-engineers individually customized human skin starting off from a very small piece of
patient’s skin. Because CUTISS’ skin closely resembles human skin, minimal scarring occurs after surgery.
Sectors
News
Promising progress for therapies against critical medical needs (startupticker.ch)
CHF 56M boost for CUTISS and its next-generation skin graft (venturelab.swiss)
CUTISS raises additional CHF 31 million to support ongoing Phase 3 trials (startupticker.ch)
Milestones achievements for life sciences startups (startupticker.ch)
Medtechs expand their global footprint with key partners (startupticker.ch)
Another year, another record by female-led startups (startupticker.ch)
Medtech startups make positive clinical progress (startupticker.ch)
Swiss medtechs maintain momentum (startupticker.ch)
Positive progress in addressing unmet medical needs (startupticker.ch)
The most promising Swiss biotech startups and scale-ups of 2024, according to investors (TOP 100)
Daniela Marino: what I wish I knew before starting CUTISS (venturelab.swiss)
CUTISS reports positive Phase 2 results for reconstructive skin surgery (startupticker.ch)
CUTISS secures CHF 25 million in Series C Funding and advances to Phase 3 clinical trials (venturelab.swiss)
CUTISS attracts CHF 25 million and enters Phase 3 clinical trials (startupticker.ch)
Swiss medtech startups enter next development phase (startupticker.ch)
Swiss startups in the spotlight: a global media perspective (startupticker.ch)
Cash and honorary awards for Swiss innovators (startupticker.ch)
Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million (startupticker.ch)
Positive from CUTISS’ Phase I and Phase II clinical studies (startupticker.ch)
The 18 most promising biotech startups, according to investors (TOP 100)
Videos and Presentations
Startup Champions Seed Night 2018